Learn the key differences between obstructive and nonobstructive HCM, including how your specific diagnosis can impact ...

If you have hypertrophic cardiomyopathy (HCM) and are experiencing symptoms such as shortness of breath, chest pain, ...

Your heart is a muscle. As Dr. Noah Moss, an advanced heart failure and transplant cardiologist at the Mount Sinai Fuster Hospital in New York City, puts it, “a very special muscle, but a muscle.” ...

In this survey of 1,297 members of the HCMA, symptoms of chest pain, dyspnea, palpitations, syncope, and lightheadedness were reported by over half. As expected, exertion was a significant trigger of ...

Hypertrophic cardiomyopathy is a genetic heart condition characterized by the thickening of the heart muscle, leading to ...

China NMPA approves Sanofi’s Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome: Paris Saturday, January 17, 2026, 11:00 Hrs ...

Despite HCM’s strong genetic basis, patients residing in lower-income or more socially deprived areas faced significantly ...

MYQORZO is indicated for the treatment of adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to improve functional capacity and symptoms. MYQORZO is contraindicated with ...